Apr 25, 2022
This video covers two important new topics. First, CDC admits that COVID booster effectiveness against symptomatic infection, plummets to 45.5% after just 3 months. Second, in a new study, Leronlimab, a monoclonal antibody, is showing promise as a Long Covid treatment, but not for the reasons we thought it would. So in this video, I’ll explain the pertinent details of all this new data. We’ll go through my Substack posts together that thoroughly explain each topic. Also, I’ll show you some graphs and images to help you better understand all of this.
Here are the Substack posts covered in this video: